{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:54:14Z","timestamp":1794862454636,"version":"4.9.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To assess efficacy of the levonorgestrel-releasing intrauterine device (LNG-IUD) for treatment of complex atypical hyperplasia or low-grade endometrial cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>This retrospective case series included all patients treated with the LNG-IUD for complex atypical hyperplasia or early-grade endometrial cancer from January 2003 to June 2013. Response rates were calculated and the association of response with clinicopathologic factors, including age, body mass index, and uterine size, was determined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Forty-six patients diagnosed with complex atypical hyperplasia or early-grade endometrial cancer were treated with the LNG-IUD. Of 32 evaluable patients at the 6-month time point, 15 had complex atypical hyperplasia (47%), nine had G1 endometrial cancer (28%), and eight had grade 2 endometrial cancer (25%). Overall response rate was 75% (95% CI 57\u201389) at 6 months; 80% (95% CI 52\u201396) in complex atypical hyperplasia, 67% (95% CI 30\u201393) in grade 1 endometrial cancer, and 75% (CI 35\u201397) in grade 2 endometrial cancer. Of the clinicopathologic features evaluated, there was a trend toward the association of lack of exogenous progesterone effect in the pathology specimen with nonresponse to the IUD (<jats:italic toggle=\"yes\">P<\/jats:italic>=.05). Median uterine diameter was 1.3 cm larger in women who did not respond to the IUD (<jats:italic toggle=\"yes\">P<\/jats:italic>=.04).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Levonorgestrel-releasing IUD therapy for the conservative treatment of complex atypical hyperplasia or early-grade endometrial cancer resulted in return to normal histology in a majority of patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000002390","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T14:57:16Z","timestamp":1512572236000},"page":"109-116","source":"Crossref","is-referenced-by-count":165,"title":["Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device"],"prefix":"10.1097","volume":"131","author":[{"given":"Navdeep","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell R.","family":"Broaddus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L.","family":"Urbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyla","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Milbourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Schmeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa A.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela T.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro T.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Ramondetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane C.","family":"Bodurka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon N.","family":"Westin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/cncr.21649","article-title":"Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Zaino","year":"2006","journal-title":"Cancer"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.AOG.0000154151.14516.f7","article-title":"Risk factors for young premenopausal women with endometrial cancer","volume":"105","author":"Soliman","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R5-20230711","first-page":"1531","article-title":"Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review","volume":"11","author":"Kaaks","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R6-20230711","first-page":"940","article-title":"Radical hysterectomy in obese women","volume":"80","author":"Soisson","year":"1992","journal-title":"Obstet Gynecol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/jnci\/91.13.1131","article-title":"Risk of endometrial cancer following estrogen replacement with and without progestins","volume":"91","author":"Weiderpass","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-0029-1242998","article-title":"Role of progesterone in endometrial cancer","volume":"28","author":"Kim","year":"2010","journal-title":"Semin Reprod Med"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ygyno.2004.06.045","article-title":"Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review","volume":"95","author":"Ramirez","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J Clin Oncol"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00404-013-2826-8","article-title":"A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women","volume":"288","author":"Shan","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2013.11.007","article-title":"Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer","volume":"133","author":"Gonthier","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1999.17.6.1736","article-title":"Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group","volume":"17","author":"Thigpen","year":"1999","journal-title":"J Clin Oncol"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/annonc\/mdq463","article-title":"Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women","volume":"22","author":"Minig","year":"2011","journal-title":"Ann Oncol"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ygyno.2004.09.010","article-title":"Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma","volume":"95","author":"Giannopoulos","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R17-20230711","first-page":"580","article-title":"Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma","volume":"82","author":"Bahamondes","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ygyno.2005.10.030","article-title":"Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia","volume":"101","author":"Vereide","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.maturitas.2006.12.004","article-title":"Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up","volume":"57","author":"Wildemeersch","year":"2007","journal-title":"Maturitas"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ygyno.2017.04.006","article-title":"Nonoperative management of atypical endometrial hyperplasia and grade 1 endometrial cancer with the levonorgestrel intrauterine device in medically ill post-menopausal women","volume":"146","author":"Baker","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/1471-0528.12499","article-title":"Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial","volume":"121","author":"Orbo","year":"2014","journal-title":"BJOG"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2010.10.004","article-title":"Conservative treatment of early endometrial cancer: preliminary results of a pilot study","volume":"120","author":"Laurelli","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/IGC.0000000000000493","article-title":"European Society of Gynecological Oncology Task Force for Fertility Preservation: clinical recommendations for fertility-sparing management in young endometrial cancer patients","volume":"25","author":"Rodolakis","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ygyno.2016.04.542","article-title":"Society of Gynecologic Oncology 2016 annual meeting: highlights and context","volume":"141","author":"Moore","year":"2016","journal-title":"Gynecol Oncol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201801000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T18:12:18Z","timestamp":1689099138000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201801000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002390","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}